U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C57H86N2O14
Molecular Weight 1023.2977
Optical Activity UNSPECIFIED
Defined Stereocenters 17 / 17
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ILS-920

SMILES

CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)[C@@H]3CC[C@@H](ON3C4=CC=CC=C4)\C=C(C)\[C@H](C[C@@H]5CC[C@@H](C)[C@@](O)(O5)C(=O)C(=O)N6CCCC[C@H]6C(=O)O2)OC)CC[C@H]1O

InChI

InChIKey=WZFNBQBUDJACCD-ZSYWEHCUSA-N
InChI=1S/C57H86N2O14/c1-33-26-37(5)51(62)53(70-10)52(63)38(6)27-34(2)47(61)32-49(35(3)28-40-20-24-46(60)50(30-40)69-9)71-56(66)45-18-14-15-25-58(45)55(65)54(64)57(67)39(7)19-21-42(72-57)31-48(68-8)36(4)29-43-22-23-44(33)59(73-43)41-16-12-11-13-17-41/h11-13,16-17,27,29,33-35,37,39-40,42-46,48-50,52-53,60,63,67H,14-15,18-26,28,30-32H2,1-10H3/b36-29+,38-27+/t33-,34+,35+,37+,39+,40-,42-,43+,44-,45-,46+,48-,49-,50+,52+,53-,57+/m0/s1

HIDE SMILES / InChI
ILS 920 (previously known as WAY-265920) was developed for the treatment of stroke. ILS-920 binds selectively to the immunophilin FKBP52 and to the β1-subunit of L-type voltage-gated calcium channels (VGCC). ILS 920 successfully completed phase I clinical trial where was determine the safety, tolerability, pharmacokinetics, and pharmacodynamics after administration of ascending single intravenous (IV) doses to healthy adult subjects. However, information about the further development of this drug is not available.

Approval Year

PubMed

PubMed

TitleDatePubMed
Molecular docking study of macrocycles as Fk506-binding protein inhibitors.
2015-06
Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities.
2008-01-08

Sample Use Guides

Unknown
Route of Administration: Intravenous
Name Type Language
ILS 920
Preferred Name English
ILS-920
Common Name English
WAY-265920
Code English
3,4,9,10,13,14,15,16,18,21,22,23,24,25,26,27,32,33,34,34A-EICOSAHYDRO-9,27-DIHYDROXY-3-((1R)-2-((1S,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHYL)-10,21-DIMETHOXY-6,8,12,14,20,26-HEXAMETHYL-16-PHENYL-23,27-EPOXY-15,18-ETHENOPYRIDO(2,1-R)(1,16,2,19)
Systematic Name English
23,27-EPOXY-15,18-ETHENOPYRIDO(2,1-R)(1,16,2,19)DIOXADIAZACYCLOHENTRIACONTINE-1,5,11,28,29(6H,12H,31H)-PENTONE, 3,4,9,10,13,14,15,16,18,21,22,23,24,25,26,27,32,33,34,34A-EICOSAHYDRO-9,27-DIHYDROXY-3-((1R)-2-((1S,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-ME
Systematic Name English
Code System Code Type Description
PUBCHEM
58974612
Created by admin on Tue Apr 01 16:41:34 GMT 2025 , Edited by admin on Tue Apr 01 16:41:34 GMT 2025
PRIMARY
DRUG BANK
DB15422
Created by admin on Tue Apr 01 16:41:34 GMT 2025 , Edited by admin on Tue Apr 01 16:41:34 GMT 2025
PRIMARY
FDA UNII
F2D5P81X82
Created by admin on Tue Apr 01 16:41:34 GMT 2025 , Edited by admin on Tue Apr 01 16:41:34 GMT 2025
PRIMARY
CAS
892494-07-4
Created by admin on Tue Apr 01 16:41:34 GMT 2025 , Edited by admin on Tue Apr 01 16:41:34 GMT 2025
PRIMARY
SMS_ID
300000041430
Created by admin on Tue Apr 01 16:41:34 GMT 2025 , Edited by admin on Tue Apr 01 16:41:34 GMT 2025
PRIMARY